Kura Oncology Inc
USPTO Trademark & Patent Filings
Trademark applications and grants for Kura Oncology Inc. Kura Oncology Inc has 10 trademark applications. The latest application filed is for "CASPIAN THERAPEUTICS"
| Patent Application | Date |
|---|---|
| METHODS OF TREATING ACUTE MYELOID LEUKEMIA WITH FARNESYLTRANSFERASE INHIBITORS 20220305001 - 17/608086 Gualberto; Antonio | 2022-09-29 |
| METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS 20220168296 - 17/599937 Gualberto; Antonio | 2022-06-02 |
| METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS 20220143006 - 17/438893 Gualberto; Antonio | 2022-05-12 |
| METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS 20220142983 - 17/435276 Gualberto; Antonio | 2022-05-12 |
| METHODS OF TREATING SQUAMOUS CELL CARCINOMAS WITH FARNESYLTRANSFERASE INHIBITORS 20220117927 - 17/488194 Burrows; Francis ; et al. | 2022-04-21 |
| SEC | 0001422143 | Kura Oncology, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 